NCT01896934View on ClinicalTrials.gov

Frontal Hypoperfusion Effects on Antidepressant Outcomes in Late-Life Depression

PHASE4CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Major Depressive Disorder
Interventions
DRUG

Sertraline

50-200mg daily

Trial Locations (1)

37212

Vanderbilt University, Nashville

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Vanderbilt University

OTHER

NCT01896934 - Frontal Hypoperfusion Effects on Antidepressant Outcomes in Late-Life Depression | Biotech Hunter | Biotech Hunter